Related Experiment Video
Updated: Nov 9, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using
Inna Chervoneva1, Boris Freydin1, Brian Hipszer1
1Thomas Jefferson University.
Abstract:
In this work, we develop an ordinary differential equations (ODE) model of physiological regulation of glycemia in type 1 diabetes mellitus (T1DM) patients in response to meals and intravenous insulin infusion. Unlike for majority of existing mathematical models of glucose-insulin dynamics, parameters in our model are estimable from a relatively small number of noisy observations of plasma glucose and insulin concentrations. For estimation, we adopt the generalized smoothing estimation of nonlinear dynamic systems of Ramsay et al. (2007). In this framework, the ODE solution is approximated with a penalized spline, where the ODE model is incorporated in the penalty. We propose to optimize the generalized smoothing by using penalty weights that minimize the covariance penalties criterion (Efron, 2004). The covariance penalties criterion provides an estimate of the prediction error for nonlinear estimation rules resulting from nonlinear and/or non-homogeneous ODE models, such as our model of glucose-insulin dynamics. We also propose to select the optimal number and location of knots for B-spline bases used to represent the ODE solution. The results of the small simulation study demonstrate advantages of optimized generalized smoothing in terms of smaller estimation errors for ODE parameters and smaller prediction errors for solutions of differential equations. Using the proposed approach to analyze the glucose and insulin concentration data in T1DM patients we obtained good approximation of global glucose-insulin dynamics and physiologically meaningful parameter estimates.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Diabetes Mellitus: Type 2 and Gestational
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...

